STK32A
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
serine/threonine kinase 32A | Ensembl:ENSG00000169302 | HGNC:HGNC:28317 | PA134932545 | 5q32 |
GO terms in STK32A
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IBA | GO:0018105 | peptidyl-serine phosphorylation |
BP | IBA | GO:0035556 | intracellular signal transduction |
CC | IEA | GO:0005886 | plasma membrane |
MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
MF | IEA | GO:0005524 | ATP binding |
MF | IEA | GO:0046872 | metal ion binding |
Gene expression in normal tissue: STK32A
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in STK32A
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD126 | Tipifarnib | 7 |
iGMDRD427 | ABT737 | 5 |
iGMDRD280 | CYTOCHALASIN B | 2 |
iGMDRD375 | GW-405833 | 2 |
iGMDRD474 | Avrainvillamide | 5 |
iGMDRD270 | Ciclosporin | 2 |
iGMDRD513 | BML-259 | 1 |
iGMDRD255 | SB225002 | 2 |
iGMDRD802 | 4-methylfasudil | 2 |
iGMDRD171 | Pemetrexed | 2 |
iGMDRD782 | DC-45-A2 | 5 |
iGMDRD294 | Batimastat | 2 |
iGMDRD309 | 17AAG | 1 |
iGMDRD187 | BRD9876 | 2 |
iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 3 |
iGMDRD74 | Idarubicin | 5 |
iGMDRD100 | Zebularine | 3 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD562 | Navitoclax | 3 |
iGMDRD506 | Fedratinib | 3 |
iGMDRD64 | Parbendazole | 2 |
iGMDRD451 | Serdemetan | 2 |
iGMDRD512 | nutlin 3 | 1 |
iGMDRD150 | RITA | 3 |
iGMDRD85 | Ursolic acid | 1 |
iGMDRD314 | Tanespimycin | 3 |
iGMDRD154 | NSC23766 | 4 |
iGMDRD137 | Indisulam | 5 |
iGMDRD158 | NSC141540 | 5 |
iGMDRD872 | BRD7137 | 2 |
iGMDRD662 | JQ-1 | 2 |
iGMDRD300 | Tozasertib | 4 |
iGMDRD505 | Pevonedistat | 1 |
iGMDRD886 | Compound 1541A | 2 |
iGMDRD353 | PD0325901 | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in STK32A